that seems to be how ONCS operates. They did the same thing with IL--12 in dogs, let someone else prove it, then step in and take it further. Though I have my doubts in this case that IL-15 will ever be taken to trials, I think they got it to prevent competition with their IL12 by someone else
My guess guti is that he was hired for the design of the new electroporation device. Once it was patented, and the two companies were hired to make all the adapters, his job was pretty well done. It is not like he was going to hand build every device.
usually has to do with endpoints and data collection. Doubles the difficulty when you do investigator sponsored because you have an IRB to do as well.
Yesterday I went back and looked at your post from the 13th where you discussed a 21 day wait time. that would put it next tue/wed. As you said, it is approved, I'm sure there is a screening process, and there are other melanoma trials that UCSF is conducting so they want to make sure patients get into the right trial for them.
he's delusional, only guy on earth that will post for over a year about a stock he has no financial interest in. Rather sad actually
has to be something at UCSF with their IRB process, or capacity to do research. Doubt we will ever know the reason
what a wreck that is. Greece is trying to figure out how to pay debts without having to feel the pain of their irresponsibility. At least we know that Russel Micrcap will rebalance today
twiz, no the rules are that they have 21 days from start of trial to list it on clinicaltrials website.
I would also wonder where she is located at. Currently ONCS has facilities in Washington and San Diego, however shortly here they will consolidate all operations in San Diego only. If she lives in Washington and is unwilling or unable to move.....
yup, analysts are questionable, sometimes right, sometimes wrong, and sometimes have alternative motives. They have to have a good track record to be taken seriously, but Maxim, H.C. Wainright, Zacks, and all the others get paid by companies, Hedges, Institutions to make recommendations. As I said, I figure it is a new analyst covering that just looked at past track record, or they have a client that wants a large position. Either way it is irrelevant to me.
yes, it is legit. My guess would be when ONCS uplisted it changed analysts inside Zacks. The new analyst just looked at ONCS stock performance to date and said "strong sell", without doing any analysis of the technology. Analysts understand financials, and market movement, they can't predict the science, so they can not make a recommendation on the chance of success. Nothing has changed for the bad with ONCS since Zacks put out the $4 (now $80) PT 6 months ago. It still comes down to converting non responders.
Yes, sorry still working on coffee. The way I read it is that he has served since Nov 2004, does not give a finish date so I figured he was still there. Either way, it does not take an expert to balance a budget, so if this guy has 25yrs, I'm sure he brings something to the table. A non-event in my book
Do not forget he has been at SpaceEx the entire time, still there as far as I can tell
There was nothing in the PR to suggest he was hired from within. He is obviously a very experienced CFO, to suggest he had a lower position in ONCS is laughable. As to why the old CFO is leaving, who knows, personal reason, found a better job, why do people move or change jobs? That is not Bolting.
Heck even Vista Capital put that in their report, IRB approval has to come before the trial. We know they now have IRB, and they should start next week.
1. They want others to drive the price of their stock up
2. Because they are paid, or have no life
3. Fortunately I can't even imagine